Infectious Diseases Virtual Partnering Event
December 2-4, 2020 | Virtual Conference
The Infectious Diseases Virtual Partnering Event is a face-to-face targeted meetings where top biotechs and biopharmaceutical companies will meet, network and partner to accelerate infectious diseases pipelines and bring new treatment options to patients worldwide. This event will leverage Inova Software and Biotechnology Innovation Organization (BIO)'s biopharma industry expertise, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide.
62nd ASH Annual Meeting and Exposition
December 5-8, 2020 I Virtual Conference
The 62nd ASH Annual Meeting and Exposition is the the world's most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology.
39th Annual J.P. Morgan Healthcare Conference
January 11-14, 2020 I Virtual Conference
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, brining together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. The hundreds of companies presenting run the gamut, from start-ups to those with more than $300 billion in market cap, and encompass the entire global healthcare landscape, including pharmaceutical firms, healthcare service providers, profit and not-for-profits, and medical device companies.
2021 Biotech Showcase
January 11-15, 2021 I Virtual Conference
Biotech Showcase is an investor conference, during JPM 2020, devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences.
BIO CEO & Investor Digital Conference
February 16-18, 2021 I Virtual Conference
Now in its 22nd year, the 2021 Biotechnology Innovation Organization (BIO) CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts, and senior biotechnology executives, in one location. The virtual 2021 event will showcase the BIO perspective on the new U.S. Congressional agenda, the record setting pacing of biotech IPOs and the hottest clinical developments and industry catalysts.
12th Annual CUGH Conference
February 16-18, 2021 I Virtual Conference
The theme of the 12th Annual Consortium of Universities for Global Health is “Addressing Critical Gaps in Global Health and Development.” Over 1800 scientists, students and implementers from academia, NGOs, government and the private sector will present, learn and collaborate to address some of the pressing challenges our world faces. Attendees will have many opportunities to engage, learn, contribute, and collaborate in a dynamic, inspiring environment.
IMCAS World Congress 2021
January 28-30, 2021 I Paris, France
IMCAS marks two decades of being at the forefront of multi-specialty conferences dedicated to aesthetic science. A record of 12,000 delegates, from dermatology, plastic surgery, and related professions, will be seizing this exceptional opportunity to explore the hottest topics related to the medical aesthetic field. The conference will be a hybrid congress with new products and activities to gain the exposure from the prominent physicians and industry players in aesthetics both physically and digitally. In addition to hundreds of the world’s experts and innovators sharing their insights, IMCAS Annual World Congress will also host 250 international exhibiting companies.
DIA Europe 2021
March 15-19, 2021 I Virtual Conference
DIA Europe 2021 is the largest and most forward-looking neutral healthcare conference in Europe. This annual healthcare meeting is event for all life science professionals working in drug development, from discovery to marketed use. It also reflects DIA’s strategic initiatives across several Thought Leadership streams, including Clinical Development & Operations, Regulatory Science & Operations, Value and Access, Medical Affairs and many others.
13th Asia Pacific Pediatrics Congress
November 25-26, 2020 I Virtual Conference
Asian Pediatrics 2020 will be an innovative and informative International conference reflecting the direction of Pediatrics in the 21st century and offers a wide range of diversions to participants of all backgrounds. This Pediatric conference provides an excellent opportunity to discuss the latest developments within the field. The conference runs with the theme “Meeting the Challenges in the field of Pediatrics.”
International Conference on Neurology and Neural Disorders
December 14-15, 2020 I Virtual Conference
Neurology Research Conference 2020 will join world-class professors, scientists, researchers, students, perfusionist, neurologist to discuss methodology for ailment remediation for neuro diseases and health disorders. The conference is planned to give various information that will keep helpful specialists next to each other of the issues impacting the expectations, finding and treatment of neuro diseases. It also provides the opportunity for clinicians, scientists, doctors and researchers from all over the world to gather and learn the latest advances in the field of Neurology and healthcare and to exchange scientific ideas and experiences in a distinctive environment.
BIO Asia International Conference
March 9-10, 2021 I Tokyo, Japan
The BIO Asia International Conference brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market and throughout the region. Companies with more than 460 therapeutic assets from more than 25 countries pursued Partnering discussions at the Tokyo conference.